跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
LABIGAT 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
LABIGAT 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Pharmathen S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 28, 2025
Approval ID
f60887b5484886d4
Company
Pharmathen S.A.
Type
Standard
Approval Details
Approval Id
f60887b5484886d4
Drug Cima Aemps Name
LABIGAT 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
90472
Holder Company Name
Pharmathen S.A.
Marketing Company Name
Pharmathen S.A.
Holder Company Detail Path
/organization/pharmathen-s-a
Marketing Company Detail Path
/organization/pharmathen-s-a
Authorization Date
2025-07-28
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
500 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Pharmathen S.A.
Company Detail Path
/organization/pharmathen-s-a
Company Information
Pharmaceutical Company Name
PHARMATHEN S.A.
Country Name
Greece
City Name
pallini,sterea ellada and evoia,country_gr
Address
6 Dervenakion
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 28, 2025
Approval ID
f60887b5484886d4
Type
Standard
Back to CIMA-AEMPS Approvals
LABIGAT 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details